Dr Aishwarya Prasad, MD, MPH | |
11400 Se 6th St Ste 200, Bellevue, WA 98004-6423 | |
(425) 620-4266 | |
Not Available |
Full Name | Dr Aishwarya Prasad |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 11400 Se 6th St Ste 200, Bellevue, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1487036828 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | 278499 (Massachusetts) | Secondary |
2084P0800X | Psychiatry & Neurology - Psychiatry | MD.MD.61271802 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Aishwarya Prasad, MD, MPH 11400 Se 6th St Ste 200, Bellevue, WA 98004-6423 Ph: (425) 620-4266 | Dr Aishwarya Prasad, MD, MPH 11400 Se 6th St Ste 200, Bellevue, WA 98004-6423 Ph: (425) 620-4266 |
News Archive
The $320 billion package of Medicare and Medicaid cuts President Obama announced yesterday as part of his plan to reduce deficit spending would effectively end the Children's Health Insurance Program, Sen. John D. Rockefeller IV said Tuesday. Rockefeller, D-W.Va., a leading advocate of the program on Capitol Hill, was referring specifically to a part of the plan, known as the "blended rate" proposal that would start in 2017.
Massachusetts on Tuesday launched a statewide health information exchange that will allow health care providers to share electronic health information as they seek to improve coordination of care, lower costs and increase patient safety. Gov. Deval Patrick successfully sent his health data from 907-bed Massachusetts General Hospital in Boston to 659-bed Baystate Medical Center in Springfield as part of the launch.
Galderma Pharma S.A., a global specialty pharmaceutical company focused on dermatology, and CollaGenex Pharmaceuticals, Inc. has announced a definitive agreement pursuant to which Galderma's U.S. holding company, Galderma Laboratories, Inc., will acquire all of the outstanding shares of CollaGenex at a price of $16.60 per share in cash, representing approximately $420 million for the equity of CollaGenex.
Geron Corporation today announced the enrollment of the first patient in the company's clinical trial of human embryonic stem cell (hESC)-derived oligodendrocyte progenitor cells, GRNOPC1. The primary objective of this Phase I study is to assess the safety and tolerability of GRNOPC1 in patients with "complete" American Spinal Injury Association (ASIA) Impairment Scale grade A thoracic spinal cord injuries. Participants in the study must be newly injured and receive GRNOPC1 within 14 days of the injury.
› Verified 7 days ago
Ted W Farrand, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 13451 Se 36th St, Bellevue, WA 98006 Phone: 425-562-1337 Fax: 425-562-1331 | |
Dr. Ashok Shimoji-krishnan, MD, MPH Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 13451 Se 36th St, Bellevue, WA 98006 Phone: 425-562-1337 Fax: 425-562-3802 | |
Dr. Romelia Perez, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1611 116th Ave Ne, Suite 132, Bellevue, WA 98004 Phone: 206-795-9797 | |
Dr. Richard Cecil Geary Iii, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1750 112th Ave Ne, B102, Bellevue, WA 98004 Phone: 425-688-5460 Fax: 425-739-4667 | |
Dr. Edward William Freedman, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 1621 114th Ave Se, Suite 221, Bellevue, WA 98004 Phone: 425-455-9900 Fax: 425-688-9987 | |
Ms. Claire Pastor, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1400 112th Ave Se Ste 100, Bellevue, WA 98004 Phone: 425-462-9511 Fax: 425-462-8894 | |
Dr. Megan Christine Riddle, MD PHD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1231 116th Ave Ne Ste 350, Bellevue, WA 98004 Phone: 425-454-1010 Fax: 425-880-5816 |